Colloidal gold NPs have been engineered to deliver both a tolerogenic aryl hydrocarbon receptor (AHR) ligand and a proinsulin peptide to induce tolerogenic DCs that promote CD4+Foxp3+ Treg generation in vivo and prevent T1D in mice (60). Here, FOXP3 is linked to type 1 diabetes mellitus.